COMMUNIQUÉS West-GlobeNewswire

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
10/04/2026
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the [...]
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
10/04/2026
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc [...]
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
10/04/2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- [...]
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
10/04/2026
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
10/04/2026
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc [...]
Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026
10/04/2026
ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026 Orion will publish Interim Report for January–March 2026 on Thursday [...]
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
10/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its shareholders and holders of [...]
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
10/04/2026
Allschwil, Switzerland – April 10, 2026 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the [...]
Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging
10/04/2026
Cambridge, UK, April 10, 2026 (GLOBE NEWSWIRE) -- On April 8th local time in the UK, the international academic conference Frontiers in Aging, Longevity and Regeneration was held at the University of Cambridge. Jointly [...]
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
10/04/2026
Manhattan Mental Health Counseling becomes an in-network TRICARE provider for New York, accepting TRICARE Select and Reserve Select for virtual therapy at Fort Hamilton, Fort Drum, West Point, Camp Smith, and statewide [...]
Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update
10/04/2026
A 2026 informational release covering what the Leanzene BHB + apple cider vinegar gummy label discloses, where published ingredient research supports category-level claims at studied dosages, how proprietary blend [...]
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
10/04/2026
A 2026 informational report examining Vita Smart Cup Massager's marketing claims, device specifications not disclosed on the product page, cupping and red light research context, return policy fine print, and key [...]
FDA Accepts NDA for TLX101-Px (Pixclara®)
10/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug Administration (FDA) [...]
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
09/04/2026
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced [...]
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
09/04/2026
A new patient resource from a leading cosmetic dentist in Stamford, CT addresses the fears, misconceptions, and outdated beliefs that prevent adults from exploring modern cosmetic dentistry options. STAMFORD, CT, April [...]
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
09/04/2026
WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN ® Nasal Spray for [...]
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/04/2026
EMPAVELI ® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced proteinuria, [...]
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
09/04/2026
EMPAVELI MD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de glomérulonéphrite [...]
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
09/04/2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026 [...]

Pages